ADE regimen

View Patient Information

A regimen consisting of high-dose cytarabine (Ara-C), daunorubicin and etoposide, that is used for the treatment of pediatric and adult acute myeloid leukemia (AML).

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	ADE AraC-daunorubicin-etoposide regimen cytarabine-daunorubicin-etoposide regimen cytarabine/daunorubicin/etoposide high-dose cytarabine-daunorubicin-etoposide regimen high-dose cytarabine/daunorubicin/etoposide high-dose cytarabine/daunorubicin/etoposide regimen MRC AML10 study-ADE regimen
Abbreviation:	ARA-C/DNR/VP-16

ADE regimen

Search NCI's Drug Dictionary